Targeting signal transduction pathways in metastatic breast cancer: a comprehensive review.
about
The impact of Bevacizumab (Avastin) on survival in metastatic solid tumors--a meta-analysis and systematic reviewMulti-level reproducibility of signature hubs in human interactome for breast cancer metastasis.Activated MET is a molecular prognosticator and potential therapeutic target for malignant peripheral nerve sheath tumorsSU11248, a selective tyrosine kinases inhibitor suppresses breast tumor angiogenesis and growth via targeting both tumor vasculature and breast cancer cells.Beta-blocker drug therapy reduces secondary cancer formation in breast cancer and improves cancer specific survivalGenomic classification of the RAS network identifies a personalized treatment strategy for lung cancerSkp2 is a promising therapeutic target in breast cancer.Testing for differentially expressed genetic pathways with single-subject N-of-1 data in the presence of inter-gene correlation.Molecular Biomarkers for Prediction of Targeted Therapy Response in Metastatic Breast Cancer: Trick or Treat?Angiogenesis and breast cancer.Primary systemic therapy in HER2-amplified breast cancer: a clinical review.ERBB3 (HER3) is a key sensor in the regulation of ERBB-mediated signaling in both low and high ERBB2 (HER2) expressing cancer cells.Human umbilical cord Wharton's jelly stem cell (hWJSC) extracts inhibit cancer cell growth in vitro.Pertuzumab and trastuzumab: the rationale way to synergy.Obtaining and characterization of monoclonal antibodies against recombinant extracellular domain of human epidermal growth factor receptor 2.Novel inhibitors of breast cancer relevant kinases Brk and HER2
P2860
Q26824086-410CE0EE-8CF5-4087-9B2A-B936B8E1DAC5Q33741210-6A367DF2-A827-4C25-8B98-D0BDA966370EQ35053276-20DA70C7-4821-4582-83FD-7953E5205D33Q35592095-CE599415-84B5-41A1-A4FE-98B423710A2DQ35640094-5D014C89-E922-422D-BEAC-35EF2AF1A9F7Q35670290-C044FDBD-3719-4674-86B6-5E02801CE222Q35687208-F7C98859-7053-4925-94D2-BE47AC19CB53Q36383597-01259CCE-14B1-42A1-ABCE-DB69B9FEA849Q37631514-89FB8780-DBB2-45EE-8F26-AA08BAFDDEE7Q37800804-30590071-9EDF-40EC-8EBF-AECB57496DB5Q38048814-0CEB629D-BA79-43B8-8949-423F5FFA0E70Q39206148-737B1F34-AC8B-4942-9E49-39CEFF7E087DQ39406770-63AA9050-4B79-48B6-85DB-441B1A4D194AQ39701009-617A7701-299C-4EC7-9254-C16744F340D4Q47646487-E9D71F08-B8F5-4A79-88DB-7B84676CF14CQ58860058-C2E015C5-9A43-4B77-9F8E-FB3BD13DA3D1
P2860
Targeting signal transduction pathways in metastatic breast cancer: a comprehensive review.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Targeting signal transduction ...... ancer: a comprehensive review.
@ast
Targeting signal transduction ...... ancer: a comprehensive review.
@en
type
label
Targeting signal transduction ...... ancer: a comprehensive review.
@ast
Targeting signal transduction ...... ancer: a comprehensive review.
@en
prefLabel
Targeting signal transduction ...... ancer: a comprehensive review.
@ast
Targeting signal transduction ...... ancer: a comprehensive review.
@en
P2093
P2860
P1433
P1476
Targeting signal transduction ...... ancer: a comprehensive review.
@en
P2093
Helen Louise Ashurst
Lee S Rosen
Linnea Chap
P2860
P304
P356
10.1634/THEONCOLOGIST.2009-0145
P577
2010-03-03T00:00:00Z